A safer strategy for tackling Parkinson’s
See more below…
Appropriate product claims will be made to comply with regulatory requirements in various countries and individual markets. This private information is solely to help highlight scientific efficacy. A partial listing of the science-backed nutraceuticals in this formulation is included below.
The U.S. National Library of Medicine reports on Parkinson’s stating, “Nutraceuticals are compounds derived from natural food sources that have certain therapeutic value which has opened doors to alternative strategies to tackle Parkinson’s.”
They add, “Notably, nutraceuticals are able to position themselves as a ‘safer’ strategy due to the fact that they are naturally derived compounds, therefore possibly having less side effects.”
The formula’s strategy is to employ nutraceuticals with human clinical research demonstrating efficacy for addressing specific core symptoms--offering relief from this serious health challenge.
Nutraceuticals have comparatively few, if any, side effects. And with few exceptions, our formulation may be taken with pharmaceuticals.
Some evidence shows that certain specified doses of coenzyme Q10 daily, slows functional decline in people with early Parkinson's disease.
Nicotinamide adenine dinucleotide (NADH)—the active form of vitamin B3 in the body—effectively raises the level of dopamine in the brain. NADH supplementation reduced symptoms and improved brain function in people with Parkinson’s disease.